

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 5.85083437 |
| 2 | glutamate secretion (GO:0014047) | 5.72589531 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.69659158 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.66958438 |
| 5 | synaptic vesicle maturation (GO:0016188) | 5.50632117 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.45296088 |
| 7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.45033423 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.33287889 |
| 9 | neuronal action potential propagation (GO:0019227) | 5.23302617 |
| 10 | vocalization behavior (GO:0071625) | 5.17309000 |
| 11 | locomotory exploration behavior (GO:0035641) | 5.02491689 |
| 12 | neuron cell-cell adhesion (GO:0007158) | 5.02176861 |
| 13 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.83029016 |
| 14 | protein localization to synapse (GO:0035418) | 4.80397204 |
| 15 | presynaptic membrane assembly (GO:0097105) | 4.75520917 |
| 16 | regulation of synaptic vesicle transport (GO:1902803) | 4.71452942 |
| 17 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.70057217 |
| 18 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.61446877 |
| 19 | presynaptic membrane organization (GO:0097090) | 4.59699573 |
| 20 | cerebellar granule cell differentiation (GO:0021707) | 4.41602107 |
| 21 | synaptic transmission, glutamatergic (GO:0035249) | 4.38745478 |
| 22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.33259403 |
| 23 | neurotransmitter secretion (GO:0007269) | 4.31792888 |
| 24 | negative regulation of cell killing (GO:0031342) | 4.28472979 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.28472979 |
| 26 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.26342245 |
| 27 | neuron-neuron synaptic transmission (GO:0007270) | 4.26022054 |
| 28 | glutamate receptor signaling pathway (GO:0007215) | 4.22420226 |
| 29 | regulation of ARF protein signal transduction (GO:0032012) | 4.14277913 |
| 30 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.12068247 |
| 31 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.11339208 |
| 32 | modulation by symbiont of host immune response (GO:0052553) | 4.11339208 |
| 33 | positive regulation by symbiont of host defense response (GO:0052509) | 4.11339208 |
| 34 | modulation by symbiont of host defense response (GO:0052031) | 4.11339208 |
| 35 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.11339208 |
| 36 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.11339208 |
| 37 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.03557397 |
| 38 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.00996114 |
| 39 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.00272135 |
| 40 | postsynaptic membrane organization (GO:0001941) | 3.96613214 |
| 41 | exploration behavior (GO:0035640) | 3.94582819 |
| 42 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.92351912 |
| 43 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.91352552 |
| 44 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.89934390 |
| 45 | positive regulation of membrane potential (GO:0045838) | 3.85451878 |
| 46 | gamma-aminobutyric acid transport (GO:0015812) | 3.80177272 |
| 47 | long-term synaptic potentiation (GO:0060291) | 3.74610087 |
| 48 | regulation of postsynaptic membrane potential (GO:0060078) | 3.72184014 |
| 49 | amino acid import (GO:0043090) | 3.71715865 |
| 50 | regulation of neurotransmitter secretion (GO:0046928) | 3.70438477 |
| 51 | sodium ion export (GO:0071436) | 3.69612008 |
| 52 | macrophage activation involved in immune response (GO:0002281) | 3.69361507 |
| 53 | dendritic spine morphogenesis (GO:0060997) | 3.67232743 |
| 54 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.64652124 |
| 55 | neuron recognition (GO:0008038) | 3.62700249 |
| 56 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.61793011 |
| 57 | neurotransmitter transport (GO:0006836) | 3.59263833 |
| 58 | regulation of synaptic plasticity (GO:0048167) | 3.58709194 |
| 59 | long-term memory (GO:0007616) | 3.52245881 |
| 60 | regulation of synapse structural plasticity (GO:0051823) | 3.52114234 |
| 61 | synaptic vesicle endocytosis (GO:0048488) | 3.51971680 |
| 62 | positive regulation of synapse maturation (GO:0090129) | 3.49384635 |
| 63 | layer formation in cerebral cortex (GO:0021819) | 3.48606551 |
| 64 | transmission of nerve impulse (GO:0019226) | 3.47752971 |
| 65 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.46638685 |
| 66 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.46043690 |
| 67 | axonal fasciculation (GO:0007413) | 3.42835485 |
| 68 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.40717209 |
| 69 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.39288847 |
| 70 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.37856752 |
| 71 | regulation of neurotransmitter transport (GO:0051588) | 3.36066152 |
| 72 | adult walking behavior (GO:0007628) | 3.34855036 |
| 73 | mechanosensory behavior (GO:0007638) | 3.34251074 |
| 74 | axon ensheathment in central nervous system (GO:0032291) | 3.32051449 |
| 75 | central nervous system myelination (GO:0022010) | 3.32051449 |
| 76 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.30895446 |
| 77 | auditory behavior (GO:0031223) | 3.29899181 |
| 78 | L-amino acid import (GO:0043092) | 3.29886658 |
| 79 | regulation of regulated secretory pathway (GO:1903305) | 3.29545377 |
| 80 | regulation of neurotransmitter levels (GO:0001505) | 3.28749928 |
| 81 | detection of other organism (GO:0098543) | 3.28475491 |
| 82 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.26040352 |
| 83 | cellular potassium ion homeostasis (GO:0030007) | 3.24009448 |
| 84 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.23980627 |
| 85 | negative regulation of type 2 immune response (GO:0002829) | 3.23600474 |
| 86 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.23219136 |
| 87 | positive regulation of neurotransmitter transport (GO:0051590) | 3.21872587 |
| 88 | microglial cell activation (GO:0001774) | 3.21824721 |
| 89 | negative regulation of neurotransmitter transport (GO:0051589) | 3.21379962 |
| 90 | positive regulation of mast cell activation (GO:0033005) | 3.21297497 |
| 91 | response to histamine (GO:0034776) | 3.18862131 |
| 92 | regulation of vesicle fusion (GO:0031338) | 3.18022588 |
| 93 | neutrophil activation involved in immune response (GO:0002283) | 3.17869348 |
| 94 | membrane depolarization (GO:0051899) | 3.15050047 |
| 95 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.14741127 |
| 96 | proline transport (GO:0015824) | 3.14301077 |
| 97 | neuromuscular process controlling posture (GO:0050884) | 3.14088207 |
| 98 | respiratory burst (GO:0045730) | 3.10012647 |
| 99 | membrane hyperpolarization (GO:0060081) | 3.09827813 |
| 100 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.09288956 |
| 101 | detection of bacterium (GO:0016045) | 3.06535654 |
| 102 | signal complex assembly (GO:0007172) | 3.05570836 |
| 103 | regulation of dendritic spine development (GO:0060998) | 3.05185875 |
| 104 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.05140505 |
| 105 | positive regulation of mast cell degranulation (GO:0043306) | 3.05140505 |
| 106 | neuromuscular process controlling balance (GO:0050885) | 3.04550894 |
| 107 | positive regulation of synaptic transmission (GO:0050806) | 3.04157826 |
| 108 | regulation of synaptic transmission (GO:0050804) | 3.04106378 |
| 109 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.03921760 |
| 110 | positive regulation of synapse assembly (GO:0051965) | 3.03751711 |
| 111 | cell differentiation in hindbrain (GO:0021533) | 3.00809403 |
| 112 | learning (GO:0007612) | 3.00282578 |
| 113 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.97344710 |
| 114 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.97272342 |
| 115 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.96656045 |
| 116 | synaptic transmission (GO:0007268) | 2.96142065 |
| 117 | regulation of respiratory system process (GO:0044065) | 2.96046930 |
| 118 | neurotransmitter uptake (GO:0001504) | 2.95899570 |
| 119 | synapse assembly (GO:0007416) | 2.95587598 |
| 120 | response to auditory stimulus (GO:0010996) | 2.95411270 |
| 121 | dendrite morphogenesis (GO:0048813) | 2.94092764 |
| 122 | activation of protein kinase A activity (GO:0034199) | 2.93851251 |
| 123 | positive regulation of Rap GTPase activity (GO:0032854) | 2.93270040 |
| 124 | neuronal ion channel clustering (GO:0045161) | 2.93053139 |
| 125 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.92366656 |
| 126 | regulation of exocytosis (GO:0017157) | 2.92352196 |
| 127 | startle response (GO:0001964) | 2.91986212 |
| 128 | synaptic vesicle transport (GO:0048489) | 2.90368353 |
| 129 | establishment of synaptic vesicle localization (GO:0097480) | 2.90368353 |
| 130 | regulation of synapse maturation (GO:0090128) | 2.89938496 |
| 131 | detection of molecule of bacterial origin (GO:0032490) | 2.89206782 |
| 132 | regulation of glutamate secretion (GO:0014048) | 2.89199425 |
| 133 | behavioral response to cocaine (GO:0048148) | 2.89075566 |
| 134 | positive regulation of regulated secretory pathway (GO:1903307) | 2.88438236 |
| 135 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.88345909 |
| 136 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.82745546 |
| 137 | response to peptidoglycan (GO:0032494) | 2.81217469 |
| 138 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.81040855 |
| 139 | response to host immune response (GO:0052572) | 2.80868126 |
| 140 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.80868126 |
| 141 | detection of external biotic stimulus (GO:0098581) | 2.78060857 |
| 142 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.76936147 |
| 143 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.76729407 |
| 144 | regulation of mast cell degranulation (GO:0043304) | 2.74377358 |
| 145 | myeloid cell activation involved in immune response (GO:0002275) | 2.74048837 |
| 146 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.70249379 |
| 147 | positive regulation of dendritic spine development (GO:0060999) | 2.70230236 |
| 148 | vesicle docking involved in exocytosis (GO:0006904) | 2.68673701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.66285236 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.09483969 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.15983680 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.07631718 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.01415545 |
| 6 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.70886228 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.69001868 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.69001868 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.65808470 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.58134726 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48067109 |
| 12 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.47660046 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.47657873 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.46861457 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.44755043 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.44589005 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.43774758 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.36636762 |
| 19 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.34606186 |
| 20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.33698135 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.29342840 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.26984815 |
| 23 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 2.20748021 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.20020123 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.19337784 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.15632881 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.12436461 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.10931772 |
| 29 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.99397916 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.98276090 |
| 31 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.95641017 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.90434611 |
| 33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.88516285 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.84346966 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.83190558 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.80452275 |
| 37 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.80189946 |
| 38 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.78642789 |
| 39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.77160270 |
| 40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.72055330 |
| 41 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70222039 |
| 42 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.65014818 |
| 43 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.59009037 |
| 44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.57463275 |
| 45 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.56073147 |
| 46 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.56053184 |
| 47 | KDM2B_26808549_Chip-Seq_K562_Human | 1.55622160 |
| 48 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.53287659 |
| 49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.49801012 |
| 50 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.47945946 |
| 51 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47518269 |
| 52 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47211211 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.45486039 |
| 54 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45442284 |
| 55 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.44350209 |
| 56 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.42831661 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.42133595 |
| 58 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.41682924 |
| 59 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.41498875 |
| 60 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.40435267 |
| 61 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.38535591 |
| 62 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.37950710 |
| 63 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.37597499 |
| 64 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.35529130 |
| 65 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33599888 |
| 66 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32936500 |
| 67 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.32625924 |
| 68 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.30048793 |
| 69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29612031 |
| 70 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.29231757 |
| 71 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28910870 |
| 72 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28882329 |
| 73 | AR_25329375_ChIP-Seq_VCAP_Human | 1.28490971 |
| 74 | FUS_26573619_Chip-Seq_HEK293_Human | 1.28332479 |
| 75 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.27772330 |
| 76 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.27727263 |
| 77 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.27667573 |
| 78 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.27350507 |
| 79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27346375 |
| 80 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.26585802 |
| 81 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25905754 |
| 82 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24173845 |
| 83 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23753287 |
| 84 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.22067424 |
| 85 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.20828131 |
| 86 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20199240 |
| 87 | TCF4_23295773_ChIP-Seq_U87_Human | 1.18589452 |
| 88 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.18071067 |
| 89 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.16106471 |
| 90 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.15883219 |
| 91 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.15270784 |
| 92 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.13848861 |
| 93 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.10784277 |
| 94 | * AR_19668381_ChIP-Seq_PC3_Human | 1.10323214 |
| 95 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 1.10212500 |
| 96 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09974660 |
| 97 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09776912 |
| 98 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.09696582 |
| 99 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09025135 |
| 100 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08626780 |
| 101 | VDR_22108803_ChIP-Seq_LS180_Human | 1.08307613 |
| 102 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08171527 |
| 103 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06685919 |
| 104 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.06185461 |
| 105 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.06181822 |
| 106 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.05673257 |
| 107 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05294088 |
| 108 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.03896042 |
| 109 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02462451 |
| 110 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02418631 |
| 111 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02236679 |
| 112 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01567399 |
| 113 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01558061 |
| 114 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00875617 |
| 115 | * SMAD4_21741376_ChIP-Seq_ESCs_Human | 1.00839163 |
| 116 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00800269 |
| 117 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00325677 |
| 118 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00285254 |
| 119 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99682206 |
| 120 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99162947 |
| 121 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97842423 |
| 122 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.97707865 |
| 123 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.96974638 |
| 124 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.96546514 |
| 125 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96532483 |
| 126 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.95462271 |
| 127 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95403204 |
| 128 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.93335945 |
| 129 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93219734 |
| 130 | JUN_21703547_ChIP-Seq_K562_Human | 0.93069339 |
| 131 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92825837 |
| 132 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.92659653 |
| 133 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.92158437 |
| 134 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92025024 |
| 135 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.91290823 |
| 136 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90704124 |
| 137 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90688342 |
| 138 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90654370 |
| 139 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90654370 |
| 140 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89742096 |
| 141 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89512458 |
| 142 | RXR_22108803_ChIP-Seq_LS180_Human | 0.89009876 |
| 143 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.88933743 |
| 144 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.88745788 |
| 145 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.88617128 |
| 146 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.88084887 |
| 147 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.87948130 |
| 148 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.86657867 |
| 149 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85798243 |
| 150 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.85206289 |
| 151 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84795554 |
| 152 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.84387187 |
| 153 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.84132398 |
| 154 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.83152281 |
| 155 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.82998343 |
| 156 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.82677690 |
| 157 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81168758 |
| 158 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.80900043 |
| 159 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.80898042 |
| 160 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.80896550 |
| 161 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.80437596 |
| 162 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.78953766 |
| 163 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78618101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.11951427 |
| 2 | MP0003880_abnormal_central_pattern | 5.60571548 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.10322763 |
| 4 | MP0004270_analgesia | 4.07558758 |
| 5 | MP0009046_muscle_twitch | 3.50245958 |
| 6 | MP0002064_seizures | 3.42503303 |
| 7 | MP0009745_abnormal_behavioral_response | 3.42106930 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.24832577 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.01778518 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.87074166 |
| 11 | MP0002272_abnormal_nervous_system | 2.86398906 |
| 12 | MP0001486_abnormal_startle_reflex | 2.76336796 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.72143908 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.55278409 |
| 15 | MP0002736_abnormal_nociception_after | 2.48234851 |
| 16 | MP0001440_abnormal_grooming_behavior | 2.26533257 |
| 17 | MP0002067_abnormal_sensory_capabilities | 2.19371493 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.16182480 |
| 19 | MP0003724_increased_susceptibility_to | 2.13602348 |
| 20 | MP0008569_lethality_at_weaning | 2.10504827 |
| 21 | MP0003303_peritoneal_inflammation | 2.06647573 |
| 22 | MP0000778_abnormal_nervous_system | 2.04553425 |
| 23 | MP0002735_abnormal_chemical_nociception | 2.01144025 |
| 24 | MP0002733_abnormal_thermal_nociception | 1.89686946 |
| 25 | MP0001970_abnormal_pain_threshold | 1.89400827 |
| 26 | MP0004924_abnormal_behavior | 1.85855290 |
| 27 | MP0005386_behavior/neurological_phenoty | 1.85855290 |
| 28 | MP0003787_abnormal_imprinting | 1.85388293 |
| 29 | MP0003329_amyloid_beta_deposits | 1.84107121 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.78241764 |
| 31 | MP0001529_abnormal_vocalization | 1.72284151 |
| 32 | MP0002184_abnormal_innervation | 1.70642050 |
| 33 | MP0004811_abnormal_neuron_physiology | 1.70016681 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.67222067 |
| 35 | MP0004142_abnormal_muscle_tone | 1.67093267 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.64102082 |
| 37 | MP0001905_abnormal_dopamine_level | 1.63533145 |
| 38 | MP0008260_abnormal_autophagy | 1.61598259 |
| 39 | MP0000955_abnormal_spinal_cord | 1.61177114 |
| 40 | MP0000920_abnormal_myelination | 1.59696128 |
| 41 | MP0003879_abnormal_hair_cell | 1.58184443 |
| 42 | MP0004885_abnormal_endolymph | 1.58099433 |
| 43 | MP0003436_decreased_susceptibility_to | 1.57412113 |
| 44 | MP0001835_abnormal_antigen_presentation | 1.56722194 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.55402158 |
| 46 | MP0002066_abnormal_motor_capabilities/c | 1.53075473 |
| 47 | MP0006276_abnormal_autonomic_nervous | 1.50750745 |
| 48 | MP0002882_abnormal_neuron_morphology | 1.49751813 |
| 49 | MP0002822_catalepsy | 1.49671412 |
| 50 | MP0002419_abnormal_innate_immunity | 1.40288135 |
| 51 | MP0003633_abnormal_nervous_system | 1.40056211 |
| 52 | MP0004742_abnormal_vestibular_system | 1.38025017 |
| 53 | MP0005671_abnormal_response_to | 1.33218508 |
| 54 | MP0003123_paternal_imprinting | 1.31540377 |
| 55 | MP0001984_abnormal_olfaction | 1.30633441 |
| 56 | MP0003631_nervous_system_phenotype | 1.29680001 |
| 57 | MP0003122_maternal_imprinting | 1.27236648 |
| 58 | MP0001986_abnormal_taste_sensitivity | 1.23457735 |
| 59 | MP0003690_abnormal_glial_cell | 1.20738762 |
| 60 | MP0001502_abnormal_circadian_rhythm | 1.20163623 |
| 61 | MP0005025_abnormal_response_to | 1.17716477 |
| 62 | MP0001800_abnormal_humoral_immune | 1.16540111 |
| 63 | MP0002229_neurodegeneration | 1.16515472 |
| 64 | MP0001188_hyperpigmentation | 1.16352903 |
| 65 | MP0002152_abnormal_brain_morphology | 1.15849249 |
| 66 | MP0004145_abnormal_muscle_electrophysio | 1.14068254 |
| 67 | MP0004858_abnormal_nervous_system | 1.12861841 |
| 68 | MP0001963_abnormal_hearing_physiology | 1.11636351 |
| 69 | MP0003632_abnormal_nervous_system | 1.10575967 |
| 70 | MP0005645_abnormal_hypothalamus_physiol | 1.09844436 |
| 71 | MP0006082_CNS_inflammation | 1.08661541 |
| 72 | MP0002909_abnormal_adrenal_gland | 1.08575501 |
| 73 | MP0001485_abnormal_pinna_reflex | 1.07329695 |
| 74 | MP0003634_abnormal_glial_cell | 1.03929200 |
| 75 | MP0002723_abnormal_immune_serum | 1.02449785 |
| 76 | * MP0001819_abnormal_immune_cell | 1.02259202 |
| 77 | * MP0002420_abnormal_adaptive_immunity | 1.01930333 |
| 78 | MP0005000_abnormal_immune_tolerance | 1.00767192 |
| 79 | MP0001790_abnormal_immune_system | 0.98175717 |
| 80 | MP0005387_immune_system_phenotype | 0.98175717 |
| 81 | MP0005310_abnormal_salivary_gland | 0.98138051 |
| 82 | MP0000751_myopathy | 0.96115839 |
| 83 | MP0000685_abnormal_immune_system | 0.95187900 |
| 84 | MP0002452_abnormal_antigen_presenting | 0.95180884 |
| 85 | MP0005166_decreased_susceptibility_to | 0.91796234 |
| 86 | MP0005171_absent_coat_pigmentation | 0.90685231 |
| 87 | MP0008872_abnormal_physiological_respon | 0.89677711 |
| 88 | MP0009785_altered_susceptibility_to | 0.88739138 |
| 89 | MP0005551_abnormal_eye_electrophysiolog | 0.87703374 |
| 90 | MP0008874_decreased_physiological_sensi | 0.86515814 |
| 91 | MP0004130_abnormal_muscle_cell | 0.86098990 |
| 92 | MP0002752_abnormal_somatic_nervous | 0.84670404 |
| 93 | MP0004510_myositis | 0.84388719 |
| 94 | MP0002069_abnormal_eating/drinking_beha | 0.84383221 |
| 95 | MP0009278_abnormal_bone_marrow | 0.84037223 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.82791038 |
| 97 | MP0003866_abnormal_defecation | 0.80163209 |
| 98 | MP0000631_abnormal_neuroendocrine_gland | 0.79111651 |
| 99 | MP0005623_abnormal_meninges_morphology | 0.76092703 |
| 100 | MP0001177_atelectasis | 0.75877389 |
| 101 | MP0000604_amyloidosis | 0.75105798 |
| 102 | MP0003191_abnormal_cellular_cholesterol | 0.70527916 |
| 103 | MP0001664_abnormal_digestion | 0.69851170 |
| 104 | MP0000716_abnormal_immune_system | 0.68909620 |
| 105 | MP0008877_abnormal_DNA_methylation | 0.67597788 |
| 106 | MP0003045_fibrosis | 0.67589630 |
| 107 | MP0004085_abnormal_heartbeat | 0.66808892 |
| 108 | MP0004043_abnormal_pH_regulation | 0.66617858 |
| 109 | MP0000569_abnormal_digit_pigmentation | 0.66125782 |
| 110 | MP0001533_abnormal_skeleton_physiology | 0.66123870 |
| 111 | MP0002148_abnormal_hypersensitivity_rea | 0.65848731 |
| 112 | MP0005394_taste/olfaction_phenotype | 0.65325544 |
| 113 | MP0005499_abnormal_olfactory_system | 0.65325544 |
| 114 | MP0002398_abnormal_bone_marrow | 0.64795949 |
| 115 | MP0001943_abnormal_respiration | 0.63694977 |
| 116 | MP0010386_abnormal_urinary_bladder | 0.63671509 |
| 117 | MP0001299_abnormal_eye_distance/ | 0.63609239 |
| 118 | MP0005409_darkened_coat_color | 0.63425127 |
| 119 | MP0000026_abnormal_inner_ear | 0.62913392 |
| 120 | MP0004147_increased_porphyrin_level | 0.62307970 |
| 121 | MP0000013_abnormal_adipose_tissue | 0.61887295 |
| 122 | MP0002876_abnormal_thyroid_physiology | 0.61189940 |
| 123 | MP0003861_abnormal_nervous_system | 0.61055487 |
| 124 | MP0003075_altered_response_to | 0.61036526 |
| 125 | MP0002133_abnormal_respiratory_system | 0.60696479 |
| 126 | MP0005388_respiratory_system_phenotype | 0.60696479 |
| 127 | MP0005377_hearing/vestibular/ear_phenot | 0.59489701 |
| 128 | MP0003878_abnormal_ear_physiology | 0.59489701 |
| 129 | MP0010769_abnormal_survival | 0.58178550 |
| 130 | MP0002653_abnormal_ependyma_morphology | 0.57006642 |
| 131 | MP0002082_postnatal_lethality | 0.56776735 |
| 132 | MP0010770_preweaning_lethality | 0.56776735 |
| 133 | MP0004484_altered_response_of | 0.55820848 |
| 134 | MP0010768_mortality/aging | 0.55007435 |
| 135 | MP0003121_genomic_imprinting | 0.52810772 |
| 136 | MP0005535_abnormal_body_temperature | 0.52347283 |
| 137 | MP0003137_abnormal_impulse_conducting | 0.50442577 |
| 138 | MP0002090_abnormal_vision | 0.50347838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.85717144 |
| 2 | Myokymia (HP:0002411) | 6.18441030 |
| 3 | Epileptic encephalopathy (HP:0200134) | 5.71916268 |
| 4 | Focal seizures (HP:0007359) | 5.56642195 |
| 5 | Atonic seizures (HP:0010819) | 5.55652097 |
| 6 | Visual hallucinations (HP:0002367) | 4.53516610 |
| 7 | Febrile seizures (HP:0002373) | 4.48811463 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.34593733 |
| 9 | Hyperventilation (HP:0002883) | 4.19169904 |
| 10 | Absence seizures (HP:0002121) | 4.17081646 |
| 11 | Broad-based gait (HP:0002136) | 4.01380604 |
| 12 | Dialeptic seizures (HP:0011146) | 3.95056380 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 3.89894816 |
| 14 | Gaze-evoked nystagmus (HP:0000640) | 3.82525699 |
| 15 | Eczematoid dermatitis (HP:0000976) | 3.65965036 |
| 16 | Recurrent abscess formation (HP:0002722) | 3.60381917 |
| 17 | Generalized tonic-clonic seizures (HP:0002069) | 3.60028958 |
| 18 | Action tremor (HP:0002345) | 3.59866055 |
| 19 | Dysmetria (HP:0001310) | 3.45947751 |
| 20 | Supranuclear gaze palsy (HP:0000605) | 3.37347802 |
| 21 | Hypochromic microcytic anemia (HP:0004840) | 3.30073474 |
| 22 | Abnormality of the corticospinal tract (HP:0002492) | 3.27378207 |
| 23 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.27112210 |
| 24 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.27112210 |
| 25 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.23079743 |
| 26 | Ankle clonus (HP:0011448) | 3.20349555 |
| 27 | Scanning speech (HP:0002168) | 3.20070947 |
| 28 | Poor eye contact (HP:0000817) | 3.18115581 |
| 29 | Dysdiadochokinesis (HP:0002075) | 3.14500459 |
| 30 | Slow saccadic eye movements (HP:0000514) | 3.09113685 |
| 31 | Spastic gait (HP:0002064) | 3.07278780 |
| 32 | Abnormal eating behavior (HP:0100738) | 3.05465767 |
| 33 | Truncal ataxia (HP:0002078) | 3.00511039 |
| 34 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.95754834 |
| 35 | Amyotrophic lateral sclerosis (HP:0007354) | 2.91808657 |
| 36 | Abnormality of macrophages (HP:0004311) | 2.86357917 |
| 37 | Amblyopia (HP:0000646) | 2.84869551 |
| 38 | Annular pancreas (HP:0001734) | 2.81385659 |
| 39 | Insidious onset (HP:0003587) | 2.80887289 |
| 40 | Termporal pattern (HP:0011008) | 2.80887289 |
| 41 | Depression (HP:0000716) | 2.80493670 |
| 42 | Sensory axonal neuropathy (HP:0003390) | 2.80222330 |
| 43 | Retrobulbar optic neuritis (HP:0100654) | 2.78782569 |
| 44 | Optic neuritis (HP:0100653) | 2.78782569 |
| 45 | Excessive salivation (HP:0003781) | 2.77118540 |
| 46 | Drooling (HP:0002307) | 2.77118540 |
| 47 | Orchitis (HP:0100796) | 2.76906928 |
| 48 | Neurofibrillary tangles (HP:0002185) | 2.74584698 |
| 49 | Intention tremor (HP:0002080) | 2.72840810 |
| 50 | Myositis (HP:0100614) | 2.71970302 |
| 51 | Abnormal social behavior (HP:0012433) | 2.69367193 |
| 52 | Impaired social interactions (HP:0000735) | 2.69367193 |
| 53 | Urinary urgency (HP:0000012) | 2.64271052 |
| 54 | Pheochromocytoma (HP:0002666) | 2.58433658 |
| 55 | Memory impairment (HP:0002354) | 2.58058175 |
| 56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.57391603 |
| 57 | Obstructive sleep apnea (HP:0002870) | 2.56309851 |
| 58 | Anxiety (HP:0000739) | 2.55649377 |
| 59 | Fetal akinesia sequence (HP:0001989) | 2.55319644 |
| 60 | Agnosia (HP:0010524) | 2.55230072 |
| 61 | Hypochromic anemia (HP:0001931) | 2.53786965 |
| 62 | Impaired smooth pursuit (HP:0007772) | 2.52651951 |
| 63 | Postural instability (HP:0002172) | 2.52390189 |
| 64 | Cerebral inclusion bodies (HP:0100314) | 2.50754029 |
| 65 | Dysmetric saccades (HP:0000641) | 2.50249301 |
| 66 | Genetic anticipation (HP:0003743) | 2.48776214 |
| 67 | Progressive inability to walk (HP:0002505) | 2.47726811 |
| 68 | Tetraplegia (HP:0002445) | 2.46298887 |
| 69 | Abnormality of binocular vision (HP:0011514) | 2.46138641 |
| 70 | Diplopia (HP:0000651) | 2.46138641 |
| 71 | Urticaria (HP:0001025) | 2.45487078 |
| 72 | Chronic obstructive pulmonary disease (HP:0006510) | 2.44902793 |
| 73 | Obstructive lung disease (HP:0006536) | 2.44902793 |
| 74 | Epileptiform EEG discharges (HP:0011182) | 2.44892045 |
| 75 | Mutism (HP:0002300) | 2.44665753 |
| 76 | Amyloidosis (HP:0011034) | 2.41833904 |
| 77 | Akinesia (HP:0002304) | 2.40584978 |
| 78 | Absent speech (HP:0001344) | 2.39157547 |
| 79 | Apathy (HP:0000741) | 2.38156389 |
| 80 | Papilledema (HP:0001085) | 2.35593574 |
| 81 | Polyphagia (HP:0002591) | 2.34778518 |
| 82 | Stereotypic behavior (HP:0000733) | 2.32183765 |
| 83 | Inability to walk (HP:0002540) | 2.31522857 |
| 84 | Generalized myoclonic seizures (HP:0002123) | 2.28429454 |
| 85 | Megalencephaly (HP:0001355) | 2.27975477 |
| 86 | Mediastinal lymphadenopathy (HP:0100721) | 2.27916751 |
| 87 | Neuroendocrine neoplasm (HP:0100634) | 2.27266670 |
| 88 | Gingivitis (HP:0000230) | 2.27158531 |
| 89 | Abnormal hair whorl (HP:0010721) | 2.26609969 |
| 90 | Impaired vibratory sensation (HP:0002495) | 2.26290265 |
| 91 | Protruding tongue (HP:0010808) | 2.26124699 |
| 92 | Inappropriate behavior (HP:0000719) | 2.23741480 |
| 93 | Thickened helices (HP:0000391) | 2.23524930 |
| 94 | Meningitis (HP:0001287) | 2.22791237 |
| 95 | Diminished motivation (HP:0000745) | 2.22201200 |
| 96 | Hemiparesis (HP:0001269) | 2.21578643 |
| 97 | Lower limb muscle weakness (HP:0007340) | 2.20456174 |
| 98 | Recurrent skin infections (HP:0001581) | 2.19540689 |
| 99 | EEG with generalized epileptiform discharges (HP:0011198) | 2.17674012 |
| 100 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.17673244 |
| 101 | Rigidity (HP:0002063) | 2.17540207 |
| 102 | Gait imbalance (HP:0002141) | 2.15478694 |
| 103 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.14399928 |
| 104 | Specific learning disability (HP:0001328) | 2.13792238 |
| 105 | Limb dystonia (HP:0002451) | 2.13051039 |
| 106 | Chest pain (HP:0100749) | 2.11686853 |
| 107 | Ventricular fibrillation (HP:0001663) | 2.10282205 |
| 108 | Bradykinesia (HP:0002067) | 2.10151868 |
| 109 | Peripheral hypomyelination (HP:0007182) | 2.08249493 |
| 110 | Stomatitis (HP:0010280) | 2.08055905 |
| 111 | Disinhibition (HP:0000734) | 2.07848721 |
| 112 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.07803875 |
| 113 | Gastrointestinal infarctions (HP:0005244) | 2.07460097 |
| 114 | Hypsarrhythmia (HP:0002521) | 2.06695475 |
| 115 | Torticollis (HP:0000473) | 2.05585123 |
| 116 | Spastic tetraparesis (HP:0001285) | 2.03899885 |
| 117 | Incomplete penetrance (HP:0003829) | 2.03870479 |
| 118 | Abnormality of saccadic eye movements (HP:0000570) | 2.02870080 |
| 119 | Gait ataxia (HP:0002066) | 2.02533539 |
| 120 | Blue irides (HP:0000635) | 2.02506531 |
| 121 | Focal dystonia (HP:0004373) | 1.99800908 |
| 122 | Abnormality of the lower motor neuron (HP:0002366) | 1.99100535 |
| 123 | Sleep apnea (HP:0010535) | 1.97484958 |
| 124 | Abnormality of the labia minora (HP:0012880) | 1.97468492 |
| 125 | Abnormality of salivation (HP:0100755) | 1.95774665 |
| 126 | Keratoconjunctivitis sicca (HP:0001097) | 1.93752106 |
| 127 | Status epilepticus (HP:0002133) | 1.93386479 |
| 128 | Hemiplegia (HP:0002301) | 1.91841198 |
| 129 | Cerebral hypomyelination (HP:0006808) | 1.90029068 |
| 130 | Cellulitis (HP:0100658) | 1.89167688 |
| 131 | Rapidly progressive (HP:0003678) | 1.88847087 |
| 132 | Dementia (HP:0000726) | 1.88356795 |
| 133 | Failure to thrive in infancy (HP:0001531) | 1.84210697 |
| 134 | Clumsiness (HP:0002312) | 1.82874473 |
| 135 | Neuronal loss in central nervous system (HP:0002529) | 1.81109553 |
| 136 | Congenital primary aphakia (HP:0007707) | 1.80190724 |
| 137 | Delusions (HP:0000746) | 1.76596504 |
| 138 | Clonus (HP:0002169) | 1.75666096 |
| 139 | Psychosis (HP:0000709) | 1.74517966 |
| 140 | Retinal dysplasia (HP:0007973) | 1.73408386 |
| 141 | Postural tremor (HP:0002174) | 1.70720730 |
| 142 | Craniofacial dystonia (HP:0012179) | 1.70243128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 3.91089859 |
| 2 | EPHA4 | 3.73145032 |
| 3 | NTRK3 | 3.66985587 |
| 4 | MAP3K9 | 3.35068578 |
| 5 | MAP3K4 | 3.17987826 |
| 6 | MAP2K7 | 2.89059683 |
| 7 | DAPK2 | 2.86523651 |
| 8 | MAP3K12 | 2.85311989 |
| 9 | MARK1 | 2.46867938 |
| 10 | MINK1 | 2.31697906 |
| 11 | PAK6 | 2.27123492 |
| 12 | PRPF4B | 2.22738189 |
| 13 | MAP2K4 | 1.98068754 |
| 14 | PLK2 | 1.95935271 |
| 15 | DAPK1 | 1.92134819 |
| 16 | TNIK | 1.77634233 |
| 17 | NTRK2 | 1.66053931 |
| 18 | MAP3K11 | 1.65504216 |
| 19 | CCNB1 | 1.64820854 |
| 20 | STK39 | 1.60831344 |
| 21 | CAMKK2 | 1.58654232 |
| 22 | CAMKK1 | 1.53852656 |
| 23 | KSR2 | 1.51263117 |
| 24 | KSR1 | 1.50183337 |
| 25 | BLK | 1.47187829 |
| 26 | PNCK | 1.46481252 |
| 27 | * CDK5 | 1.46277914 |
| 28 | RIPK4 | 1.45808296 |
| 29 | UHMK1 | 1.40777974 |
| 30 | NTRK1 | 1.34572067 |
| 31 | GRK5 | 1.31189667 |
| 32 | MAPK13 | 1.28236819 |
| 33 | ARAF | 1.27122054 |
| 34 | BCR | 1.25432951 |
| 35 | SGK223 | 1.21227671 |
| 36 | SGK494 | 1.21227671 |
| 37 | CAMK2B | 1.20794896 |
| 38 | MAP2K3 | 1.19110813 |
| 39 | CSK | 1.17852285 |
| 40 | PRKCG | 1.14957767 |
| 41 | MAP4K1 | 1.13055683 |
| 42 | CAMK2A | 1.11153354 |
| 43 | PRKD3 | 1.09994458 |
| 44 | IRAK4 | 1.09369490 |
| 45 | AKT3 | 1.04599229 |
| 46 | MAPK12 | 1.03279835 |
| 47 | MAP3K1 | 1.01763938 |
| 48 | TYRO3 | 1.01599079 |
| 49 | * CDK18 | 0.99848270 |
| 50 | CAMK1G | 0.98995520 |
| 51 | SYK | 0.96272996 |
| 52 | * CDK15 | 0.94742163 |
| 53 | * CDK14 | 0.94720975 |
| 54 | FES | 0.88638894 |
| 55 | * JAK2 | 0.86847342 |
| 56 | WNK1 | 0.86237571 |
| 57 | CSNK1G2 | 0.84850670 |
| 58 | MAP3K13 | 0.84436389 |
| 59 | PTK2B | 0.84368012 |
| 60 | TYK2 | 0.83630845 |
| 61 | * CDK11A | 0.82124476 |
| 62 | BMPR2 | 0.80956206 |
| 63 | CAMK1 | 0.80943639 |
| 64 | FGR | 0.79829051 |
| 65 | GRK6 | 0.77806546 |
| 66 | CSF1R | 0.77133131 |
| 67 | PRKCZ | 0.77027601 |
| 68 | NEK6 | 0.76829154 |
| 69 | SGK2 | 0.75976808 |
| 70 | MAP3K2 | 0.75573925 |
| 71 | SIK3 | 0.74383852 |
| 72 | STK38 | 0.73668796 |
| 73 | ROCK2 | 0.73103300 |
| 74 | PAK3 | 0.70961945 |
| 75 | YES1 | 0.69511155 |
| 76 | RIPK1 | 0.69230571 |
| 77 | * OXSR1 | 0.68801690 |
| 78 | CAMK2D | 0.68799416 |
| 79 | FGFR2 | 0.68141091 |
| 80 | HCK | 0.67887685 |
| 81 | DYRK1A | 0.66950256 |
| 82 | CAMK2G | 0.66143376 |
| 83 | PHKG2 | 0.63890290 |
| 84 | PHKG1 | 0.63890290 |
| 85 | DAPK3 | 0.63718695 |
| 86 | SGK1 | 0.63578454 |
| 87 | MAPKAPK5 | 0.63094919 |
| 88 | SIK2 | 0.62009108 |
| 89 | BRAF | 0.61741258 |
| 90 | PRKCH | 0.61559361 |
| 91 | MARK2 | 0.61233544 |
| 92 | IRAK2 | 0.59464125 |
| 93 | JAK1 | 0.59184016 |
| 94 | SGK3 | 0.59122333 |
| 95 | RAF1 | 0.57623516 |
| 96 | NME1 | 0.57218441 |
| 97 | TAOK2 | 0.56914585 |
| 98 | PKN1 | 0.56205986 |
| 99 | PRKCE | 0.56151123 |
| 100 | LIMK1 | 0.55937429 |
| 101 | RET | 0.55264140 |
| 102 | ZAP70 | 0.55162914 |
| 103 | TAOK1 | 0.54396215 |
| 104 | CAMK1D | 0.53741844 |
| 105 | MAP3K7 | 0.52901409 |
| 106 | * STK11 | 0.51173463 |
| 107 | MAP3K5 | 0.51129072 |
| 108 | MAP2K6 | 0.50107400 |
| 109 | WNK4 | 0.49991026 |
| 110 | TNK2 | 0.48692746 |
| 111 | LYN | 0.47813002 |
| 112 | CSNK1G3 | 0.47724971 |
| 113 | EPHB1 | 0.47591773 |
| 114 | FYN | 0.47329064 |
| 115 | MAP3K6 | 0.47096025 |
| 116 | BTK | 0.46893872 |
| 117 | DYRK1B | 0.45279160 |
| 118 | CAMK4 | 0.44719087 |
| 119 | TSSK6 | 0.43544907 |
| 120 | PRKG2 | 0.43133452 |
| 121 | WNK3 | 0.42440544 |
| 122 | PINK1 | 0.41418590 |
| 123 | RPS6KA3 | 0.40595941 |
| 124 | MAPK7 | 0.39380646 |
| 125 | ALK | 0.38762821 |
| 126 | * PDK1 | 0.38097388 |
| 127 | ADRBK1 | 0.37857601 |
| 128 | LATS2 | 0.37725265 |
| 129 | MAPK10 | 0.37334955 |
| 130 | * PDPK1 | 0.34840261 |
| 131 | CSNK1A1L | 0.34355871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.02934551 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.82852199 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.80765873 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.68438664 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.64882194 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.64716805 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.64293147 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.60009936 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.56305613 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.47925097 |
| 11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.35436116 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.17335913 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.14120716 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.92015438 |
| 15 | Long-term depression_Homo sapiens_hsa04730 | 1.91218928 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.87387504 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.82358850 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.81977075 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.77099507 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.73252389 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.70316351 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.62528705 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.60899484 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.59361010 |
| 25 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.54336515 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.53337587 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.52133425 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.49714454 |
| 29 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.49053502 |
| 30 | Allograft rejection_Homo sapiens_hsa05330 | 1.43233556 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.42664851 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.41825237 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.39593939 |
| 34 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.34059170 |
| 35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.33505903 |
| 36 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.32330919 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.31779984 |
| 38 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.31756913 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.31193580 |
| 40 | * Axon guidance_Homo sapiens_hsa04360 | 1.30396714 |
| 41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.28870817 |
| 42 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.21074547 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.18500884 |
| 44 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.16786289 |
| 45 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.15873236 |
| 46 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.14976380 |
| 47 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.13790506 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.13199597 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08446169 |
| 50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03806888 |
| 51 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02453142 |
| 52 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.00737107 |
| 53 | Glioma_Homo sapiens_hsa05214 | 0.93066516 |
| 54 | Melanogenesis_Homo sapiens_hsa04916 | 0.92949392 |
| 55 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.92297072 |
| 56 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.90286744 |
| 57 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.89655205 |
| 58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89415802 |
| 59 | Asthma_Homo sapiens_hsa05310 | 0.89182616 |
| 60 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.88234145 |
| 61 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.86846659 |
| 62 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82467571 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81117815 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79123592 |
| 65 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78223174 |
| 66 | Phototransduction_Homo sapiens_hsa04744 | 0.77458753 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77171560 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76836060 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76295251 |
| 70 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75965840 |
| 71 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.72971311 |
| 72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72769409 |
| 73 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72696823 |
| 74 | Influenza A_Homo sapiens_hsa05164 | 0.71980173 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71631279 |
| 76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.71505464 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71172472 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68666751 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68069035 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 0.65836601 |
| 81 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65250445 |
| 82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65112265 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65003788 |
| 84 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.64962769 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64931769 |
| 86 | Alzheimers disease_Homo sapiens_hsa05010 | 0.63674145 |
| 87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63632008 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62118954 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.60036668 |
| 90 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.56643955 |
| 91 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.56365534 |
| 92 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.55913223 |
| 93 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.55323511 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 0.53598252 |
| 95 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.52579037 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.52426273 |
| 97 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.52298009 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51815041 |
| 99 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51571096 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51557080 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51457837 |
| 102 | Circadian rhythm_Homo sapiens_hsa04710 | 0.50268722 |
| 103 | Alcoholism_Homo sapiens_hsa05034 | 0.48945890 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48890712 |
| 105 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.48668418 |
| 106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47665266 |
| 107 | Phagosome_Homo sapiens_hsa04145 | 0.47229726 |
| 108 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.46561778 |
| 109 | Legionellosis_Homo sapiens_hsa05134 | 0.45564812 |
| 110 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45383567 |
| 111 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43802569 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43704751 |
| 113 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42936548 |
| 114 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42913011 |
| 115 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42050310 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36616853 |
| 117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36217738 |
| 118 | Parkinsons disease_Homo sapiens_hsa05012 | 0.34506137 |
| 119 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.33357075 |
| 120 | Tight junction_Homo sapiens_hsa04530 | 0.31242733 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31111984 |
| 122 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.30349103 |
| 123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30068253 |
| 124 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29080148 |
| 125 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.28860872 |
| 126 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.27108917 |
| 127 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26731110 |
| 128 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.25779379 |
| 129 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.25251922 |
| 130 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.24775223 |
| 131 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.24153291 |
| 132 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.23889581 |

